Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15a712bc86f217e285a328a3157149f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b8fea71f9f474816dd8b5108ddd930 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a79faa4615b9c4626a61c602b2ecf16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217e452998bf896c2fd13666155dd345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e070c301ef7469dbb2b78b2681f878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf27ca75918bbd7cb97f4c8e9818c77b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2249e3544840596193a949fb275c020 |
publicationDate |
2022-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20220132593-A |
titleOfInvention |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists |
abstract |
Compounds according to formula I or II are useful as agonists of toll-like receptor 7 (TLR7). Such compounds can be used in the treatment of cancer, particularly in combination with anti-cancer immunotherapeutic agents or as vaccine adjuvants. |
priorityDate |
2020-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |